Navigation Links
Argon Medical Devices Announces The Launch Of OptionELITE Retrievable Vena Cava Filter And The Acquisition of Angiotech Interventional Business
Date:4/4/2013

PLANO, Texas, April 4, 2013 /PRNewswire/ -- Continuing our commitment to provide best-in-class medical devices for the prevention of recurrent pulmonary embolism (PE), Argon Medical Devices, Inc. takes another step forward with the launch of the Option™ELITE Retrievable Vena Cava Filter.  The OptionELITE IVC Filter, designed by Rex Medical, LP, provides the clinician with the same safe and trusted design now enhanced for ease of delivery and retrievability.

"Safety and retrievability are without question two of the most vital, and rare, characteristics in a best-in-class retrievable IVC filter.  Argon is pleased to be able to offer the best of these worlds by introducing the OptionELITE," stated George Leondis , President of Argon Medical Devices. "This technology provides clinicians with a safe and stable IVC filter that can be confidently deployed and retrieved while minimizing the risk of migration, penetration and fracture.  This product, along with the new Cleaner15™ Mechanical Thrombectomy System, and the recently announced acquisition of Angiotech's Interventional business, positively positions the company as a significant player in the interventional arena."

OptionELITE's enhanced retention anchor pattern provides stability and reduced retrieval force while preventing migration and reducing the risk of penetration.  The sturdy apex design has an increased capture zone for ease of snaring.  In addition, the new high performance spiral sheath remains the lowest profile IVC filter delivery system available today (6.5Fr OD, 5.0Fr ID) and has been reinforced for improved kink-resistance and pushability.

"I have used Option™ for many years.  At Weill Cornell, we had the opportunity to participate in the OptionELITE evaluation and found the device to be just as safe and stable as the Option, with no migrations and significantly easier to retrieve," said David W. Trost , MD, Associate Professor of Clinical Radiology, Weill Medical College of Cornell University in New York, New York.

Argon Medical will be featuring the OptionELITE IVC Filter at the 38th Annual Scientific Meeting of the Society of Interventional Radiology in New Orleans, Louisiana, April 13 – 18, 2013 and will be offering a hands-on simulator training experience at booth 840.

PE affects an estimated 600,000 to 1,000,000 people in the US and its incidence is increasing annually.  PE is the sudden blockage of an artery in the lung (pulmonary artery) typically blood clot (thrombus).  Emboli dislodgement can be caused by peripheral vascular disease (PVD), severe deep vein thrombosis (DVT), trauma and prolonged immobilization often following major surgical procedures.  PE occurs when these clots break loose and embolize to block pulmonary blood vessels in the lungs.  According to clinical research, if left untreated, PE has a mortality rate of 30% and is a leading cause of inpatient deaths in US hospitals. 

About Argon
Argon Medical Devices is a global manufacturer of specialty medical products headquartered in Plano, Texas.  Argon offers a diverse line of medical devices for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Critical Care procedures.  Its products include the Option™ELITE Retrievable Vena Cava Filter, Cleaner Rotational Thrombectomy Systems, and the UltraStream™ Chronic Dialysis Catheter.  The recently announced acquisition of Angiotech's Interventional business, brings best -in-class products such as BioPince™ Full Core Biopsy Instruments, Skater™ All-Purpose Drainage Systems, and Atrieve Vascular Snare™ Kits, into the Argon product portfolio.  Argon Medical Devices is a privately held portfolio company of Roundtable Healthcare Partners, which is committed to providing clinicians with innovative, technology-driven solutions to improve patient outcomes.

About Roundtable
RoundTable Healthcare Partners, based in Lake Forest, IL, is an operating-oriented private equity firm focused exclusively on the health-care industry. The partners of RoundTable have significant experience in managing, operating, acquiring and financing multibillion-dollar diversified health-care companies. RoundTable partners with companies that can benefit from its extensive industry relationships and proven operating and transaction expertise.

About Rex Medical, LP
Rex Medical, LP, based in Conshohocken, PA, is a privately held medical device company specializing in the development, manufacturing and marketing of minimally invasive medical devices targeted towards the cardiovascular, venous access, endosurgery and oncology markets. Rex Medical is ISO 13485 certified.


'/>"/>
SOURCE Argon Medical Devices, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. RoundTable Healthcare Partners and Argon Medical Devices to Acquire Angiotech Pharmaceuticals Interventional Products Business
2. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
3. Medical Device Developers - Network at BIOMEDevice Boston Next Week
4. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
5. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
6. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
7. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
8. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
9. Essential Medical Dismisses Patent Case against Masimo and Cercacor
10. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
11. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... 16, 2017  Newly published research from the CVS ... the role a private retailer can play in restricting ... published online today in the American Journal of ... remove tobacco from all CVS Pharmacy stores reduced the ... an even greater impact on those who bought cigarettes ...
(Date:2/16/2017)... -- Summary Provides understanding and access to the ... healthcare companies. ... The Global Allergy Partnering Terms and Agreements since 2010 report ... by the world,s leading healthcare companies. - Trends ... Deals listed by company A-Z, industry sector, stage of development, technology ...
(Date:2/16/2017)... , Feb 16, 2017 Research and Markets ... Diagnostics Market Analysis & Trends - Function, Application, Cancer Type, Technology ... ... Cancer Diagnostics Market is poised to grow at a CAGR of ... by 2025. Some of the prominent trends ...
Breaking Medicine Technology:
(Date:2/19/2017)... ... , ... ProBrand Glitch is a set of 30 glitch distortion logo reveals made exclusively for ... logo with a glitch reveal in just a few clicks of a mouse. Customizable glitch ... each preset. Use these presets to add a uniquely animated logo to any photos or ...
(Date:2/18/2017)... VA (PRWEB) , ... February ... ... of Change for Devicemakers , Sponsored by Axendia, **FDAnews Free Webinar**, March ... , Are manufacturers looking to reduce their regulatory burden? Pay dividends in ...
(Date:2/18/2017)... , ... February 17, 2017 , ... ... drvallecillos.com , Beverly Hills plastic surgeon Dr. Glenn Vallecillos ... , Dr. Vallecillos says, "Traditionally, plastic surgery has been centered around that idea ...
(Date:2/18/2017)... La. (PRWEB) , ... February 18, 2017 , ... ... released today provides the latest information and contact points to easily connect elderly ... home care, assisted living, and elder-care funding. It also conveys material on this ...
(Date:2/17/2017)... Diego, CA (PRWEB) , ... February 17, 2017 ... ... initiative—InvestUp—to focus on foundational and sustainable systems change designed to further positively impact ... , “The Board of Trustees has long considered it our duty to seriously ...
Breaking Medicine News(10 mins):